New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Go back to New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 341.48 -10.66 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $352.14 | 52 Week High | $114.49 | |||
| Open | $350.60 | 52 Week Low | $75.17 | |||
| Day High | $353.65 | P/E | 94.59 | |||
| Day Low | $340.79 | EPS | $3.61 | |||
| Volume | 361,889 | |||||
| (AMEX: CSLLY) | Delayed: 31.55 -0.06 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.61 | 52 Week High | $45.60 | |||
| Open | $31.66 | 52 Week Low | $33.39 | |||
| Day High | $31.67 | P/E | N/A | |||
| Day Low | $30.23 | EPS | $0.00 | |||
| Volume | 92,282 | |||||

